Abstract
Pancreatic ductal adenocarcinoma (PDAC) is a gastrointestinal malignancy with a dismal clinical outcome. Accumulating evidence suggests that activated pancreatic stellate cells (PSCs), the major producers of extracellular matrix (ECM), drive the severe stromal/desmoplastic reaction in PDAC. Furthermore, the crosstalk among PSCs, pancreatic cancer cells (PCCs) as well as other stroma cells can establish a growth-supportive tumor microenvironment (TME) of PDAC, thereby enhancing tumor growth, metastasis, and chemoresistance via various pathways. Recently, targeting stroma has emerged as a promising strategy for PDAC therapy, and several novel strategies have been proposed. The aim of our study is to give a profound review of the role of PSCs in PDAC progression and recent advances in stroma-targeting strategies.
Dokumententyp: | Zeitschriftenartikel |
---|---|
Keywords: | Pancreatic stellate cells, pancreatic ductal adenocarcinoma, tumor microenvironment, stroma-targeting strategy, tumor therapy |
Fakultät: | Medizin |
Themengebiete: | 600 Technik, Medizin, angewandte Wissenschaften > 610 Medizin und Gesundheit |
URN: | urn:nbn:de:bvb:19-epub-103168-1 |
ISSN: | 2234-943X |
Sprache: | Englisch |
Dokumenten ID: | 103168 |
Datum der Veröffentlichung auf Open Access LMU: | 05. Jun. 2023, 15:42 |
Letzte Änderungen: | 07. Dez. 2023, 16:53 |